|
End-of-day quote
Prague S.E.
17/09/2026
|
5-day change | 1st Jan Change | ||
| 113.00 CZK | +1.80% |
|
-2.59% | -33.53% |
| 06-15 | Pilulka Lékárny a.s. Auditor Raises 'Going Concern' Doubt | CI |
| 06-15 | Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 306M 14.44M 12.58M 11.9M 10.81M 20.2M 1.38B 20.3M 142M 54.82M 703M 54.24M 53.03M 2.25B | P/E 2024 |
-2.31x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 346M 16.31M 14.21M 13.45M 12.22M 22.82M 1.56B 22.93M 160M 61.93M 794M 61.27M 59.91M 2.54B | EV / Sales 2024 |
0.25x | EV / Sales 2025 | 0.57x |
| Free-Float |
49.9% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.80% | ||
| 1 week | -2.59% | ||
| 1 month | -6.61% | ||
| 3 months | -6.61% | ||
| 6 months | -9.60% | ||
| Current year | -33.53% |
| 1 week | 110 |  | 117 |
| 1 month | 110 | | 122 |
| Current year | 99 | | 177 |
| 1 year | 99 | | 190 |
| 3 years | 80 | | 420 |
| 5 years | 80 | | 1,800 |
| 10 years | 80 | | 1,800 |
| Manager | Title | Age | Since |
|---|---|---|---|
Martin Kasa
PRN | Corporate Officer/Principal | 46 | 01/01/2013 |
Petr Kasa
CEO | Chief Executive Officer | 49 | 01/01/2013 |
David Stanek
DFI | Director of Finance/CFO | - | 01/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Miloš Cebík
BRD | Director/Board Member | 46 | 25/06/2015 |
Martin Buchta
CHM | Chairman | 51 | 27/08/2020 |
Marek Krajcovic
BRD | Director/Board Member | 52 | 27/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.80% | -2.59% | -39.73% | -70.95% | 14.44M | |
| +4.55% | +4.43% | -46.65% | -11.83% | 14.11B | |
| -1.02% | +2.24% | -18.13% | -8.03% | 6.45B | |
| +4.07% | +1.49% | -53.98% | -32.93% | 6.07B | |
| +0.62% | +0.35% | -13.23% | -20.29% | 4.11B | |
| -0.17% | -1.04% | -19.09% | -38.38% | 3.14B | |
| +0.49% | +2.01% | +3.68% | -29.36% | 3.11B | |
| -3.16% | +2.78% | +65.81% | - | 2.85B | |
| +8.62% | +6.15% | -42.97% | -20.38% | 2.97B | |
| -0.46% | -2.68% | -20.57% | -8.81% | 2.42B | |
| Average | +1.53% | +1.45% | -18.49% | -26.77% | 4.52B | |
| Weighted average by Cap. | +2.24% | +1.18% | -26.42% | -18.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.3B 61.57M 53.63M 50.76M 46.11M 86.15M 5.9B 86.57M 605M 234M 3B 231M 226M 9.59B | 876M 41.37M 36.04M 34.11M 30.99M 57.89M 3.96B 58.18M 406M 157M 2.01B 155M 152M 6.45B |
| Net income | -126M -5.94M -5.17M -4.89M -4.45M -8.31M -569M -8.35M -58.28M -22.54M -289M -22.3M -21.8M -925M | -38.87M -1.83M -1.6M -1.51M -1.37M -2.57M -176M -2.58M -18.02M -6.97M -89.31M -6.89M -6.74M -286M |
| Net Debt | 38.28M 1.81M 1.57M 1.49M 1.35M 2.53M 173M 2.54M 17.74M 6.86M 87.95M 6.79M 6.64M 282M | 39.66M 1.87M 1.63M 1.54M 1.4M 2.62M 179M 2.63M 18.38M 7.11M 91.12M 7.03M 6.88M 292M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/09/26 | CZK 113.00 | +1.80% | 99 |
| 16/09/26 | CZK 111.00 | -4.72% | 198 |
| 15/09/26 | CZK 116.50 | -0.43% | 27 |
| 14/09/26 | CZK 117.00 | +2.63% | 470 |
| 11/09/26 | CZK 114.00 | -1.72% | 320 |
- Stock Market
- Stocks
- PINK Stock
Select your edition
All financial news and data tailored to specific country editions
